Publications
- Dynamics of T-cell infiltration during the course of ovarian cancer: The gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells2013 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma2013 | Second Faculty of Medicine
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response2011 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials2011 | Second Faculty of Medicine
- Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix2024 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Type I interferon and cancer2024 | Second Faculty of Medicine
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma2023 | First Faculty of Medicine, Second Faculty of Medicine
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | Second Faculty of Medicine
- Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
Loading network view...